Status:
COMPLETED
Acceptability and Efficacy of 'Fish Surimi Peptide' in Under Five Children Suffering From Moderate Acute Malnutrition
Lead Sponsor:
International Centre for Diarrhoeal Disease Research, Bangladesh
Collaborating Sponsors:
Suzuhiro Kamaboko Co., Ltd.,Japan
Conditions:
Moderate Acute Malnutrition
Eligibility:
All Genders
2-5 years
Phase:
PHASE1
Brief Summary
Protein-energy malnutrition (PEM) including moderate acute malnutrition (MAM: weight-for-height z-score \<-2 to -3, or mid upper arm circumference (MUAC) 115 to \< 125 mm) is a major cause of morbidit...
Eligibility Criteria
Inclusion
- Signed informed consent from guardian
- Ages 2 to 5 years
- WHZ\<-2 to -3or (MUAC) 115 to \< 125 mm without any edema
- Parent/guardian planning to stay in the same area for 3 to 4 months (for smooth follow up purpose)
Exclusion
- WHZ ≤ -3 z-scores or presence of bilateral pedal edema
- History of allergy to any fish product
- Anorexia, jaundice or chronic disease or any serious illness warranting hospital referral
- Any congenital anomaly
- Concurrent participation in another clinical trial with intervention to the child
Key Trial Info
Start Date :
October 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2016
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT02272543
Start Date
October 1 2014
End Date
December 1 2016
Last Update
September 25 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
icddr,b Dhaka Hospital
Dhaka, Bangladesh, 1212